Showing 6541-6550 of 9115 results for "".
- ZO Skin Health Opens in Pasadenahttps://practicaldermatology.com/news/20121203-zo_skin_health_opens_in_pasadena/2459666/ZO® Skin Health, described as a cutting-edge center that offers the latest in skin transformation and anti-aging technology and treats a wide range of skin conditions including acne, scars, large pores and skin imperfections, opened November
- New Data Show Stelara Effective for Psoriatic Arthritishttps://practicaldermatology.com/news/20121203-new_data_finds_stelara_effective_for_psoriatic_arthritis/2459669/Findings from the PSUMMIT II Phase 3 investigational study showed patients with active psoriatic arthritis receiving Stelara (ustekinumab, Jannsen) demonstrated significant improvements in signs and symptoms of the disease. Significantly more patie
- Jurlique Purely Bright Releases Clinical Resultshttps://practicaldermatology.com/news/20121128-jurlique_purely_bright_releases_clinical_results/2459672/Jurlique Purely Bright, a brightening system launched earlier this year, released clinical results on its product line. After 30 days, the system was clinically proven to help reduce dark spots. After 12 weeks, skin surface smoothness doubled at
- Physician Income "Disappointing," But Up Slightlyhttps://practicaldermatology.com/news/20121121-physician_income_disappointing_but_up_slightly/2459674/Although most physicians report that their net income is "disappointing," American physicians saw a slight uptick in income in 2012 compared to 2011, a new report shows. Specialists continue to outpace primary care physicians; 40% of the latter make less than $150,000 per year,
- Picato Approved in European Unionhttps://practicaldermatology.com/news/20121119-picato_approved_in_european_union/2459677/The European Commission has granted marketing authorization for LEO Pharma's Picato (ingenol mebutate) gel for the treatment of actinic keratosis in the European Union (EU). Picato was approved in the US earlier this year.
- Sun Pharmaceutical to Buy DUSA Pharmaceuticalshttps://practicaldermatology.com/news/20121118-sun_pharmaceutical_to_buy_dusa_pharmaceuticals/2459678/Sun Pharmaceutical Industries Ltd. will buy DUSA Pharmaceuticals Inc. for about $215 million in cash, as the India-based company looks to make a foray into the lucrative market for dermatological treatments. The deal has been unanimously approved by the boards of both companies and DUSA's board has
- Dermatology Partnerships Exploredhttps://practicaldermatology.com/news/20121115-dermatology_partnerships_explored/2459681/Research and Markets has added the "Dermatology Partnering Terms and Agreements" report to their offering. This report provides a detailed understanding and analysis of how and why companies enter dermatology
- "Cirque du CeraVe" Event in NYC Launches New CeraVe Productshttps://practicaldermatology.com/news/20121031-cirque_du_cerave_event_in_nyc_launches_new_cerave_products/2459687/The “Cirque du CeraVe” skincare launch event, held at Osteria del Circo in New York City on October, was attended by consumer, trade and dermatology media, who learned about new CeraVe product launches. The brand staged a CeraVe “Circus” complete with a professional mime, juggler, contortionist and
- Provectus Presents Data on PV-10 in Combination with Systemic Chemotherapyhttps://practicaldermatology.com/news/20121029-provectus_presents_data_on_pv-10_in_combination_with_systemic_chemotherapy/2459688/Provectus Pharmaceuticals, Inc. presented nonclinical data on PV-10 at the Society for Immunotherapy of Cancer (SITC) 27th Annual Meeting on October 26 and 27, 2012 in North Bethesda, MD. PV-10 is Provectus Pharmaceuticals' novel oncology drug design
- LEO Pharma's Taclonex Topical Suspension Approved for Body Plaqueshttps://practicaldermatology.com/news/20121029-leo_pharma_receives_fda_approval_for_taclonex_topical_suspension/2459689/LEO Pharma Inc. announced the US Food and Drug Administration (FDA) approval of Taclonex (calcipotriene and betamethasone dipropionate) Topical Suspension, 0.005%/0.064% for the treatment of body plaque psoriasis. Taclonex® Topical Suspension is